Cargando…

The biological underpinnings of therapeutic resistance in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality in the United States and has only recently achieved a 5-yr survival rate of 10%. This dismal prognosis reflects the remarkable capacity of PDAC to effectively adapt to and resist therapeutic intervention. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Beatty, Gregory L., Werba, Gregor, Lyssiotis, Costas A., Simeone, Diane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247606/
https://www.ncbi.nlm.nih.gov/pubmed/34117095
http://dx.doi.org/10.1101/gad.348523.121

Ejemplares similares